189 related articles for article (PubMed ID: 26961172)
1. Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients.
Engholm M; Mulvany MJ; Eftekhari A; Mathiassen ON; Buus NH; Christensen KL
J Hum Hypertens; 2016 Nov; 30(11):690-696. PubMed ID: 26961172
[TBL] [Abstract][Full Text] [Related]
2. Changes in blood pressure and systemic vascular resistance do not predict microvascular structure during treatment of mild essential hypertension.
Eftekhari A; Mathiassen ON; Buus NH; Gotzsche O; Mulvany MJ; Christensen KL
J Hypertens; 2012 Apr; 30(4):794-801. PubMed ID: 22306851
[TBL] [Abstract][Full Text] [Related]
3. Myocardial and forearm blood flow reserve in mild-moderate essential hypertensive patients.
Pedrinelli R; Dell'Omo G; Gimelli A; Di Bello V; Talarico L; Corchia A; Sambuceti G; Neglia D; Parodi O
J Hypertens; 1997 Jun; 15(6):667-73. PubMed ID: 9218187
[TBL] [Abstract][Full Text] [Related]
4. Disproportionally impaired microvascular structure in essential hypertension.
Eftekhari A; Mathiassen ON; Buus NH; Gotzsche O; Mulvany MJ; Christensen KL
J Hypertens; 2011 May; 29(5):896-905. PubMed ID: 21330935
[TBL] [Abstract][Full Text] [Related]
5. Effects of renal denervation on coronary flow reserve and forearm dilation capacity in patients with treatment-resistant hypertension. A randomized, double-blinded, sham-controlled clinical trial.
Engholm M; Bertelsen JB; Mathiassen ON; Bøtker HE; Vase H; Peters CD; Bech JN; Buus NH; Schroeder AP; Rickers H; Hansen KW; Poulsen PL; Kaltoft A; Christensen KL
Int J Cardiol; 2018 Jan; 250():29-34. PubMed ID: 29042091
[TBL] [Abstract][Full Text] [Related]
6. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study.
Higashi Y; Sasaki S; Nakagawa K; Ueda T; Yoshimizu A; Kurisu S; Matsuura H; Kajiyama G; Oshima T
J Am Coll Cardiol; 2000 Feb; 35(2):284-91. PubMed ID: 10676671
[TBL] [Abstract][Full Text] [Related]
7. Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment.
Mathiassen ON; Buus NH; Larsen ML; Mulvany MJ; Christensen KL
J Hypertens; 2007 May; 25(5):1027-34. PubMed ID: 17414667
[TBL] [Abstract][Full Text] [Related]
8. How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension.
High Blood Press Cardiovasc Prev; ; . PubMed ID: 29197935
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
